https://www.selleckchem.com/pr....oducts/abbv-cls-484.
Nearly 39% of the EM cohort initiated AS monitoring; age 77, White race, being married/partnered, higher median ZIP code income, and lower PSA levels were associated with initiating AS. By three years after diagnosis, 21.3% of the EM cohort had switched to AT, usually after undergoing AS monitoring procedures. We found increasing uptake of EM over time, though over 50% still received AT. About 60% of EM patients did not initiate AS monitoring, even among those with life expectancy 10 years, implying that a substantial propo
Like
Comment
Share
